An Open-Label, Two-Period, Sequential Drug Interaction Study To Evaluate The Effect Of Multiple Doses Of Desvenlafaxine Succinate Sustained Release (DVS SR) On The Pharmacokinetics Of Midazolam When Coadministered In Healthy Subjects.

Trial Profile

An Open-Label, Two-Period, Sequential Drug Interaction Study To Evaluate The Effect Of Multiple Doses Of Desvenlafaxine Succinate Sustained Release (DVS SR) On The Pharmacokinetics Of Midazolam When Coadministered In Healthy Subjects.

Completed
Phase of Trial: Phase IV

Latest Information Update: 12 Aug 2011

At a glance

  • Drugs Desvenlafaxine; Midazolam
  • Indications Anxiety disorders; Depressive disorders
  • Focus Pharmacokinetics
  • Sponsors Wyeth
  • Most Recent Events

    • 23 Aug 2010 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
    • 08 Jun 2010 Planned initiation date changed from 1 Aug 2009 to 1 Jun 2010 as reported by ClinicalTrials.gov.
    • 08 Jun 2010 Planned end date changed from 1 Oct 2009 to 1 Aug 2010 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top